Skip to content
healthcare.dev

LYBALVI

NDC 65757-654, olanzapine and samidorphan L-malate, tablet, film coated, from Alkermes, Inc..

Product NDC
65757-654
Status
Listed
Labeler
Alkermes, Inc.
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA213378
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/65757-654 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OLANZAPINE20 mg/1
  • SAMIDORPHAN L-MALATE10 mg/1

Pharmacologic classes

Atypical Antipsychotic [EPC]; Opioid Antagonist [EPC]; Opioid Antagonists [MoA]

Package NDCNDC-11Package
65757-654-41657570654411 BOTTLE in 1 CARTON (65757-654-41) / 7 TABLET, FILM COATED in 1 BOTTLE
65757-654-42657570654421 BOTTLE in 1 CARTON (65757-654-42) / 30 TABLET, FILM COATED in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/32ffddd1-4e2b-45d9-9b36-bb730167ec80
  • NADAC price for package 65757065442

    GET /v1/drugs/nadac/65757065442

Use it

Look up 65757-654 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/65757-654 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 65757-654. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.